Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Prudentia Sciences is seeking a Director of Customer Success to lead a portfolio of strategic biopharma accounts in the US. You will drive platform adoption, retention, and expansion, owning commercial outcomes and influencing product direction with senior customers.
You will oversee end-to-end implementations, onboarding workshops, executive engagements, and proactive account management to maximize value and renewal probability in a fast-growing life sciences tech environment.
Prudentia Sciences is the scientific intelligence layer powering life sciences dealmaking. We bring together expert-developed scientific diligence frameworks, AI reasoning trained on drug development, and a unified evidence base to accelerate investment in breakthrough therapies. As a trusted third party operating between buyer and seller, we help build conviction through every stage of the deal, faster. We replace fragmented workflows with a single system that surfaces what matters earlier.
Backed by GV (Google Ventures), McKesson, Iaso Ventures, Virtue, and SignalFire - and built by people who have sat on every side of the table in life sciences dealmaking - we're on a mission to bring expert scientific judgment to every deal decision, at AI scale.
We're looking for a Director of Customer Success to manage and scale a portfolio of strategic biopharma accounts. You'll own commercial outcomes for Top 25 biopharma customers, driving platform adoption, retention, and expansion to build a “business within the business”. Customer feedback from your portfolio will directly inform our product roadmap and operating model. You’ll operate with the judgment of an owner, not just execute a playbook.
Compensation Range: $170K - $200K
Prudentia Sciences is the scientific intelligence layer powering life sciences dealmaking. We bring together expert-developed scientific diligence frameworks, AI reasoning trained on drug development, and a unified evidence base to accelerate investment in breakthrough therapies. As a trusted third party operating between buyer and seller, we help build conviction through every stage of the deal, faster. We replace fragmented workflows with a single system that surfaces what matters earlier.
Backed by GV (Google Ventures), McKesson, Iaso Ventures, Virtue, and SignalFire - and built by people who have sat on every side of the table in life sciences dealmaking - we're on a mission to bring expert scientific judgment to every deal decision, at AI scale.